Ruoxi (Rosy) Hu is a seasoned biotech professional with over 10 years of experience in the industry. Currently a member of the investment team at Morningside, they focus on early-stage investments and serve as interim CEO for an incubated neuroscience company. Ruoxi has also held roles at Mass General Brigham Ventures, where they contributed to venture creation and co-founded multiple spin-outs. Their educational background includes a Ph.D. in Biological Sciences from Harvard University and a Bachelor's degree in Life Sciences from Queen's University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices